AXQ Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Sell
3,135
-552
-15% -$205K 0.13% 245
2026
Q1
$1.08M Buy
+3,687
New +$1.21M 0.14% 229
2025
Q4
Sell
-1,860
Closed -$601K 782
2025
Q3
$601K Buy
+1,860
New +$578K 0.23% 144
2025
Q1
Sell
-707
Closed -$261K 540
2024
Q4
$261K Sell
707
-470
-40% -$197K 0.12% 286
2024
Q3
$612K Sell
1,177
-954
-45% -$510K 0.18% 218
2024
Q2
$1.15M Buy
+2,131
New +$1.13M 0.27% 130
2024
Q1
Sell
-1,500
Closed -$707K 693
2023
Q4
$707K Sell
1,500
-800
-35% -$370K 0.19% 196
2023
Q3
$1M Buy
+2,300
New +$1.04M 0.35% 90

Other funds holding ELV

AXQ Capital's ELV Position: Q2 2026 in Review

AXQ Capital reduced its Elevance Health (ELV) stake by 15% in Q2 2026, selling an estimated $205K and leaving 3,135 shares worth $1.21M. The position accounts for 0.13% of the portfolio, ranked #245.

AXQ Capital first reported a position in ELV in Q3 2023 and has held it in 8 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • AXQ Capital held 3,135 shares of Elevance Health worth $1.21M as of Q2 2026.
  • AXQ Capital sold 552 Elevance Health shares in Q2 2026, an estimated $205K.
  • Elevance Health made up 0.13% of AXQ Capital's portfolio in Q2 2026, its #245 holding.
  • AXQ Capital first reported a position in Elevance Health in Q3 2023 and has held it in 8 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.